MedPath

High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma

Phase 2
Conditions
Brain and Central Nervous System Tumors
Registration Number
NCT00287924
Lead Sponsor
Children's Cancer and Leukaemia Group
Brief Summary

RATIONALE: Drugs used in chemotherapy, such as methotrexate, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.

PURPOSE: This phase II trial is studying how well high-dose methotrexate works in treating young patients with residual ependymoma.

Detailed Description

OBJECTIVES:

Primary

* Determine the activity of high-dose methotrexate as upfront-window therapy in young patients with residual ependymoma.

Secondary

* Assess the reasons why primary surgery was complete/incomplete in these patients.

* Assess the feasibility and toxicity of second-look surgery after 3 courses of high-dose methotrexate in cases where initial surgery was incomplete.

OUTLINE: This is a multicenter, open-label study.

Patients receive high-dose methotrexate IV continuously over 24 hours on days 0, 14, and 28 in the absence of disease progression or unacceptable toxicity. Patients then proceed to further chemotherapy on protocol UKCCSG-CNS-9204.

After completion of study treatment, patients are followed periodically for 9 years.

PROJECTED ACCRUAL: A total of 29 patients will be accrued for this study.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
29
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Activity of high-dose methotrexate at 6 weeks
Secondary Outcome Measures
NameTimeMethod
Assess reasons why primary surgery is complete or incomplete at diagnosis
Feasibility and toxicity of second look surgery after course 3 at 2 months
Compare functional imaging studies of ependymomas with biological characteristics of the tumors at diagnosis

Trial Locations

Locations (20)

Our Lady's Hospital for Sick Children Crumlin

🇮🇪

Dublin, Ireland

Birmingham Children's Hospital

🇬🇧

Birmingham, England, United Kingdom

Institute of Child Health at University of Bristol

🇬🇧

Bristol, England, United Kingdom

Addenbrooke's Hospital

🇬🇧

Cambridge, England, United Kingdom

Leeds Cancer Centre at St. James's University Hospital

🇬🇧

Leeds, England, United Kingdom

Leicester Royal Infirmary

🇬🇧

Leicester, England, United Kingdom

Royal Liverpool Children's Hospital, Alder Hey

🇬🇧

Liverpool, England, United Kingdom

Royal London Hospital

🇬🇧

London, England, United Kingdom

Great Ormond Street Hospital for Children

🇬🇧

London, England, United Kingdom

Royal Manchester Children's Hospital

🇬🇧

Manchester, England, United Kingdom

Scroll for more (10 remaining)
Our Lady's Hospital for Sick Children Crumlin
🇮🇪Dublin, Ireland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.